Skip to main navigation
NextCure, Inc.
  • Home
  • About Us
    • Background
    • Founder
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • FIND-IO™ Technology
  • Pipeline
  • Product Development
  • Partnering
  • Investors
    • Overview
    • News
    • Publications
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
  • Contact

Publications

Publications

March 4, 2019
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy

Tools

9000 Virginia Manor Road | Suite 200 | Beltsville, MD 20705 | USA | (240) 399-4900